Efeitos neuromusculares in vitro e in vivo do atracúrio e do rocurônio em ratos submetidos a tratamento de sete dias com carbamazepina
In vitro and in vivo neuromuscular effects of atracurium and rocuronium in rats treated with carbamazepine for seven days
Caroline Coutinho de Barcelos; Angélica de Fátima de Assunção Braga; Franklin Sarmento da Silva Braga; Gloria Braga Potério; Samanta Cristina Antoniassi Fernandes; Yoko Oshima Franco; Léa Rodrigues Simioni
Resumo
Palavras-chave
Abstract
Keywords
References
Martins RS, Martins ALC. Bloqueadores Neuromusculares. Anestesiologia: Princípios e Técnicas. 1997:308-331.
Miranda FG, Marín JS, Aränó JA. Neurofisiologia de la Union Neuromuscular. Relajantes Musculares em Anestesia y Terapia Intensiva. 2000:61-70.
Cardoso LSM, Martins CR, Tardelli MA. Efeitos da lidocaína por via venosa sobre a farmacodinâmica do rocurônio. Rev Bras Anestesiol. 2005;55:371-380.
Loyola YCS, Braga AFA, Potério GMB. Influência da lidocaína no bloqueio neuromuscular produzido pelo rocurônio: Estudo em preparação nervo frênico - diafragma de rato. Rev Bras Anestesiol. 2006;56:147-156.
Sousa SRS, Braga AFA, Potério GMB. Influência da nifedipina no bloqueio neuromuscular produzido pelo atracúrio e pelo cisatracúrio: Estudo em preparações nervo frênicodiafragma de rato. Rev Bras Anestesiol. 2006;56:157-167.
Haywood PT, Divekar N, Karalliedde LD. Concurrent medication and the neuromuscular junction. Eur J Anaesthesiol. 1999;16:77-91.
Spacek A, Kress HG. Drug interactions with muscle relaxants. Acta Anaesthesiol Scand. 1998;42(^s112):236-238.
Mei PA, Montenegro MA, Guerreiro MM. Pharmacovigilance in epileptic patients using antiepileptic drugs. Arq Neuropsiquiatr. 2006;64:198-201.
Rang HP, Dale MM, Ritter JM. Fármacos Antiepilépticos. Farmacologia. 2003:627-639.
Perucca E. An introduction to antiepileptic drugs. Epilepsia. 2005;46:31-37.
Beydoun S, Alarcón F, Mangat S. Long-term safety and tolerability of carbamazepine in painful diabetic neuropathy. Acta Neurol Scand. 2007;115:284-288.
Eisenberg E, River Y, Shifrin A. Antiepileptic drugs in the treatment of neuropathic pain. Drugs. 2007;67:1265-1289.
Alloul K, Whalley DG, Shutway F. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology. 1996;84:330-339.
Nguyen A, Ramzan I. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats. Pharmazie. 2000;55:957.
Richard A, Girard F, Girard DC. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg. 2005;100:538-544.
Tempelhoff R, Modica PA, Jellish WS. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg. 1990;71:665-669.
Spacek A, Neiger FX, Spiss CK. Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine. Acta Anaesthesiol Scand. 1997;41:1308-1311.
Spacek A, Nickl S, Neiger FX. Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin. Anesthesiology. 1999;90:1551-1555.
Spacek A, Neiger FX, Krenn CG. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology. 1999;90:109-112.
Kim JU, Lee YK, Lee YM. The effect of phenytoin on rocuronium-induced neuromuscular block in the rat phrenic nerve-hemidiaphragm preparation. J Neurosurg Anesthesiol. 2005;17:149-152.
Bulbring E. Observation on the isolated phyrenic nerve-diaphragm preparation of the rat. Br J Pharmacol. 1946;1:38-61.
Leeuwin RS, Wolters ECMJ. Effects of corticosteroids on the sciatic nerve-tibialis anterior muscle of rats treated with hemicholinium-3. Neurology. 1977;27:171-177.
Ostergaard D, Engbaek J, Viby-Mogensen J. Adverse reactions and interactions of the neuromuscular blocking drugs. Med Toxicol Adverse Drug Exp. 1989;4:351-368.
Anderson GD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998;32:554-563.
Ornstein E, Matteo RS, Schwartz AE. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology. 1987;67:191-196.
Ornstein E, Matteo RS, Weinstein JA. Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. J Clin Anesth. 1991;3:108-111.
Whalley DG, Ebrahim Z. Influence of carbamazepine on the dose-response relationship of vecuronium. Br J Anaesth. 1994;72:125-126.
Norman J. Resistance to vecuronium. Anaesthesia. 1993;48:1068-1069.
Roth S, Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology. 1987;66:691-693.
Jellish WS, Modica PA, Tempelhoff R. Accelerated recovery from pipecuronium in patients treated with chronic anticonvulsant therapy. J Clin Anesth. 1993;5:105-108.
Jellish WS, Thalji Z, Brundidge PK. Recovery from mivacurium-induced neuromuscular blockade is not affected by anticonvulsant therapy. J Neurosurg Anesthesiol. 1996;8:4-8.
Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med. 1996;334:168-175.
Alderdice MT, Trommer BA. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission. J Pharmacol Exp Ther. 1980;215:92-96.
Platt PR, Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesth Intensive Care. 1993;21:185-191.
Hartman GS, Fiamengo SA, Riker WF Jr. Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology. 1986;65:405-413.
Kohling R. Voltage-gated sodium channels in epilepsy. Epilepsia. 2002;43:1278-1295.
Stoelting RK, Hillier SC. Neuromuscular blocking drugs. Pharmacology & Physiology in Anesthetic Practice. 2006:208-250.
Norris FH Jr, Colella J, Mcfarlin D. Effect of diphenylhydantoin on neuromuscular synapse. Neurology. 1964;14:869-876.
Gray HS, Slater RM, Pollard BJ. The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia. 1989;44:379-381.
Nguyen A, Ramzan I. Acute in vitro neuromuscular effects of carbamazepine and carbamazepine-10,11-epoxide. Anesth Analg. 1997;84:886-890.
Soriano SG, Sullivan LJ, Venkatakrishnan K. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth. 2001;86:223-229.
Ebrahim ZY, Bulkey R, Roth S. Carbamazepine therapy and neuromuscular blockade with atracurium or vecuronium. Anesth Analg. 1988;67:S55.
Fisher DM, Canfell PC, Fahey MR. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology. 1986;65:6-12.
Loan PB, Connolly FM, Mirakhur RK. Neuromuscular effects of rocuronium in patients receiving beta-adrenoreceptor blocking, calcium entry blocking and anticonvulsant drugs. Br J Anaesth. 1997;78:90-91.
Kim CS, Arnold FJ, Itani MS. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology. 1992;77:500-506.
Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Ver. 1988;40:1-47.
Martyn JA, Abernethy DR, Greenblatt DJ. Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther. 1984;35:535-539.
Wood M. Plasma binding and limitation of drug access to site of action. Anesthesiology. 1991;75:721-723.
Hans P, Brichant JF, Pieron F. Elevated plasma alpha1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy. J Neurosurg Anesthesiol. 1997;9:3-7.
Pirttiaho HI, Sotaniemi EA, Pelkonen RO. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol. 1982;22:441-445.